Back to trial detailsIntake questionnaire
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Applying to Velocity Clinical Research New Smyrna Beach · Edgewater, Florida
Answer a few short questions to share with the research team.
0 of 4 answered